Attached files

file filename
8-K - CURRENT REPORT OF MATERIAL EVENTS OR CORPORATE CHANGES - Nexeo Solutions Holdings, LLCa14-6315_18k.htm

Exhibit 99.1

 

Nexeo Solutions Holdings, LLC

Management Adjusted EBITDA Reconciliation

(in thousands)

 

 

 

Q2FY13

 

Q3FY13

 

Q4FY13

 

Q1 FY14

 

LTM
Q1 FY14

 

Pro Forma
12/31/2013
LTM (1)

 

Net Income (Loss) Attributable to Nexeo Solutions

 

$

10,875

 

$

4,295

 

$

6,965

 

$

(12,846

)

$

9,289

 

$

22,160

 

Net Income (Loss) Attributable to Noncontrolling Interest

 

(106

)

597

 

1,031

 

1,656

 

3,178

 

3,178

 

Interest

 

14,197

 

15,938

 

13,836

 

14,282

 

58,253

 

59,994

 

Taxes

 

1,072

 

1,885

 

1,869

 

2,419

 

7,245

 

7,289

 

Depreciation and Amortization

 

9,715

 

9,703

 

10,550

 

11,657

 

41,625

 

47,447

 

EBITDA

 

35,753

 

32,418

 

34,251

 

17,168

 

119,590

 

140,068

 

Management add-backs (2)

 

5,803

 

6,224

 

9,476

 

4,992

 

26,495

 

31,195

 

Foreign exchange (gains) losses, net (3)

 

501

 

802

 

(510

)

110

 

903

 

903

 

Management fees (4)

 

1,542

 

1,070

 

1,164

 

1,272

 

5,048

 

5,048

 

Compensation expense related to management equity plan (non-cash)

 

574

 

276

 

291

 

281

 

1,422

 

1,422

 

Transaction and other one-time costs (5)

 

2,181

 

1,259

 

1,958

 

4,662

 

10,060

 

3,430

 

Management Adjusted EBITDA

 

$

46,354

 

$

42,049

 

$

46,630

 

$

28,485

 

$

163,518

 

$

182,066

 

 


(1)              Effective December 1, 2013, the Company acquired 100% of the outstanding shares of Chemical Specialists and Development, Inc. (“CSD”), and substantially all of the assets of STX Freight Company (“STX”) and ST Laboratories Group, LLC (“ST Laboratories”), two related businesses of CSD (collectively, the “CSD Acquisition”). Pro forma Management Adjusted EBITDA for the twelve months ended December 31, 2013 reflects the full contribution of the CSD Acquisition. Pro forma results are not necessarily inidicative of either future results of operations or results that might have been achieved had the acquisition completed at the beginning of the period.

(2)              Management adjustments associated with integration, transition, restructuring and transformational activities.

(3)              Includes net realized and unrealized foreign exchange gains and losses.

(4)              Management, monitoring, consulting and leverage fees, per the agreement with TPG Capital, L.P. (“TPG”).

(5)              Professional and transaction costs related to the acquisition of Ashland’s global distribution business, Nexeo Plaschem, the CSD Acquisition and other potential acquisitions and other one-time costs.